Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VISTA PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 VISTA PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    VISTA PHARMA
Mar-23
TEVA PHARMA
Dec-13
VISTA PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs143,489-   
Low Rs73,031-   
Sales per share (Unadj.) Rs0.32,002.2-  
Earnings per share (Unadj.) Rs-1.5125.1-  
Cash flow per share (Unadj.) Rs-1.3286.9-  
Dividends per share (Unadj.) Rs0109.49-  
Avg Dividend yield %03.4 0.0%  
Book value per share (Unadj.) Rs8.12,224.0-  
Shares outstanding (eoy) m37.56848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x39.11.6 2,404.0%   
Avg P/E ratio x-6.926.1 -26.6%  
P/CF ratio (eoy) x-7.811.4 -68.5%  
Price / Book Value ratio x1.31.5 87.7%  
Dividend payout %087.5 -0.0%   
Avg Mkt Cap Rs m3932,764,158 0.0%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m50-   
Avg. sales/employee Rs Th037,776.0-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,359.8-  
INCOME DATA
Net Sales Rs m101,697,844 0.0%  
Other income Rs m40-   
Total revenues Rs m141,697,844 0.0%   
Gross profit Rs m-44464,956 -0.0%  
Depreciation Rs m6137,238 0.0%   
Interest Rs m1233,348 0.0%   
Profit before tax Rs m-59294,369 -0.0%   
Minority Interest Rs m01,337 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-193,237 -0.0%   
Tax Rs m-2-3,594 0.1%   
Profit after tax Rs m-57106,063 -0.1%  
Gross profit margin %-442.727.4 -1,616.5%  
Effective tax rate %3.6-1.2 -298.7%   
Net profit margin %-563.96.2 -9,027.6%  
BALANCE SHEET DATA
Current assets Rs m2381,146,718 0.0%   
Current liabilities Rs m1411,000,035 0.0%   
Net working cap to sales %963.08.6 11,146.4%  
Current ratio x1.71.1 147.1%  
Inventory Days Days20791 227.6%  
Debtors Days Days40,90296 42,645.2%  
Net fixed assets Rs m296554,553 0.1%   
Share capital Rs m754,179 1.8%   
"Free" reserves Rs m2300-   
Net worth Rs m3061,885,983 0.0%   
Long term debt Rs m52868,145 0.0%   
Total assets Rs m5343,880,118 0.0%  
Interest coverage x-3.89.8 -39.1%   
Debt to equity ratio x0.20.5 36.8%  
Sales to assets ratio x00.4 4.3%   
Return on assets %-8.33.6 -231.9%  
Return on equity %-18.55.6 -329.6%  
Return on capital %-13.14.9 -264.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m-17270,548 -0.0%  
From Investments Rs m-13-95,866 0.0%  
From Financial Activity Rs m31-324,541 -0.0%  
Net Cashflow Rs m1-149,859 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.58 Rs / USD

Compare VISTA PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare VISTA PHARMA With: LYKA LABS  GUJ.THEMIS.  BERYL DRUGS  JFL LIFE SCIENCES LTD.  PARNAX LAB  



Today's Market

Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.